Delivery Order SPE2DB20D2104-SPE2DB22FR79C
Award Date 2/9/22
Potential Completion Date 2/10/22
Potential Value $33K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $25,113.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 17, 2022 and was awarded on May 16, 2022. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC enables Amerisourcebergen to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $10,219.47, was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor registered in the System for Award Management (SAM.gov). The contract has a ceiling value of $5,284.69 and an ultimate completion date of April 12, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation....
- The federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $1,177.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 18, 2023 and was awarded on August 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $10,003.75 firm-fixed-price delivery order was issued to prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $98,664.77 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $7,183.08 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets, valued at $50,443.65. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a Firm Fixed Price Delivery Order that will be completed by November 1, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and...
- This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets (90 count) to the Defense Logistics Agency (DLA). The $5,079.60 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 5, 2023, with a completion date of January 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026....